$25.08
-0.13 (-0.52%)
As of Jun 22, 9:31 PM ET ·
Analyst Consensus
Hold
36
Analysts
Very High
Coverage
Buy 15 42%
Hold 18 50%
Sell 3 8%
Price Target
Analyst Price Target +35.2% upside
Low Target $24.03
Average Target $33.90
High Target $39.81
Current Price $25.08
Current
$25.08
Target
$33.90
$24.03 $33.90 avg $39.81
Scenario Analysis
Bear Case
$24.03
-4.2%
Low target
Base Case
$33.90
+35.2%
Avg target
Bull Case
$39.81
+58.7%
High target
Risk/Reward
14.0x
Highly favorable
Price in Context
52-Week High
$28.75
-12.8% from high
52-Week Low
$23.11
+8.5% from low
50-Day SMA
$25.92
-3.2% vs SMA
200-Day SMA
$24.89
+0.8% vs SMA
RSI (14)
57.0
Neutral
Target vs 52W High
$33.90
+17.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%